Choriocarcinoma with markedly elevated serum hCG levels and negative urine hCG levels.
Ajufo
I I
II
Department of Obstetrics, Horton Hospital, Banbury, UK. ijemusne@yahoo.co.uk
Lindow
S W
SW
Canty
S H
SH
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000097:blood* / Q000188:drug therapy / Q000556:secondary / Q000652:urine*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000032:analysis*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005047:Etoposide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008727:Methotrexate / Q000627:therapeutic use; D011247:Pregnancy; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000473:pathology / Q000652:urine*; D014750:Vincristine / Q000627:therapeutic use
D018997:Chorionic Gonadotropin, beta Subunit, Human; D003609:Dactinomycin; D014750:Vincristine; D005047:Etoposide; D003520:Cyclophosphamide; D008727:Methotrexate